Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 25, 2024 | 2.76 | +5.34 |
Hansa Biopharma | HNSA | Nov 25, 2024 | 31.50 | +2.67 |
Hanza AB | HANZA | Nov 25, 2024 | 65.85 | -3.23 |
Harm Reduction Group | NOHARM | Nov 25, 2024 | 0.04 | -15.33 |
Havsfrun Investment | HAVS | Nov 25, 2024 | 14.40 | +5.11 |
Havsfrun Investment B | HAVB | Nov 25, 2024 | 14.40 | +5.11 |
Haypp Group | HAYPP | Nov 25, 2024 | 62.20 | +1.63 |
Headsent | VIMAB | Nov 25, 2024 | 7.50 | 0.00 |
Heba B | HEBAB | Nov 25, 2024 | 31.50 | +0.64 |
Hedera Group | HEGR | Nov 25, 2024 | 2.42 | 0.00 |
Heimstaden Pref | HEIMPREF | Nov 25, 2024 | 14.66 | +4.42 |
Heliospectra | HELIO | Nov 25, 2024 | 0.46 | -5.74 |
Hemnet Group | HEM | Nov 25, 2024 | 330.20 | +1.35 |
Hemply Balance | HMPLY | Nov 25, 2024 | 0.05 | +15.00 |
Hernö Gin B | HERNOB | Nov 25, 2024 | 4.08 | +5.84 |
Hexagon B | HEXAB | Nov 25, 2024 | 93.16 | +1.42 |
Hexagon Purus | HPURO | Nov 25, 2024 | 4.92 | 0.00 |
Hexatronic Group | HTRO | Nov 25, 2024 | 38.14 | +3.08 |
Hexicon | HEXI | Nov 25, 2024 | 0.19 | +13.37 |
Hexpol B | HPOLB | Nov 25, 2024 | 108.50 | +1.21 |
Hifab B | HIFAB | Nov 25, 2024 | 3.14 | -0.63 |
High Coast Distillery B | HIGHCOB | Nov 25, 2024 | 43.80 | -0.45 |
Hilbert | HILBB | Nov 25, 2024 | 5.20 | -6.14 |
HMS Networks | HMS | Nov 25, 2024 | 383.00 | +1.70 |
Hoegh Autoliners ASA | HAUTOO | Nov 25, 2024 | 127.80 | -3.55 |
Hoi Publishing AB | HOIB | Nov 25, 2024 | 0.18 | +3.53 |
Hoist Finance | HOFI | Nov 25, 2024 | 93.20 | -3.62 |
Holdflight | HOLDFL | Nov 25, 2024 | 0.18 | 0.00 |
Holmen A | HOLMA | Nov 25, 2024 | 410.00 | +0.49 |
Holmen B | HOLMB | Nov 25, 2024 | 418.20 | +1.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.